Etrasimod

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

Etrasimod as Prevention of Pouchitis

Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis

Provide Pre-approval Single Patient Expanded Access (Compassionate Use) of Etrasimod for Patients.

A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis

A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis